In Defense of Sugar: A Critique of Diet-Centrism.

Abstract:

:Sugars are foundational to biological life and played essential roles in human evolution and dietary patterns for most of recorded history. The simple sugar glucose is so central to human health that it is one of the World Health Organization's Essential Medicines. Given these facts, it defies both logic and a large body of scientific evidence to claim that sugars and other nutrients that played fundamental roles in the substantial improvements in life- and health-spans over the past century are now suddenly responsible for increments in the prevalence of obesity and chronic non-communicable diseases. Thus, the purpose of this review is to provide a rigorous, evidence-based challenge to 'diet-centrism' and the disease-mongering of dietary sugar. The term 'diet-centrism' describes the naïve tendency of both researchers and the public to attribute a wide-range of negative health outcomes exclusively to dietary factors while neglecting the essential and well-established role of individual differences in nutrient-metabolism. The explicit conflation of dietary intake with both nutritional status and health inherent in 'diet-centrism' contravenes the fact that the human body is a complex biologic system in which the effects of dietary factors are dependent on the current state of that system. Thus, macronutrients cannot have health or metabolic effects independent of the physiologic context of the consuming individual (e.g., physical activity level). Therefore, given the unscientific hyperbole surrounding dietary sugars, I take an adversarial position and present highly-replicated evidence from multiple domains to show that 'diet' is a necessary but trivial factor in metabolic health, and that anti-sugar rhetoric is simply diet-centric disease-mongering engendered by physiologic illiteracy. My position is that dietary sugars are not responsible for obesity or metabolic diseases and that the consumption of simple sugars and sugar-polymers (e.g., starches) up to 75% of total daily caloric intake is innocuous in healthy individuals.

journal_name

Prog Cardiovasc Dis

authors

Archer E

doi

10.1016/j.pcad.2018.04.007

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

10-19

issue

1

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(18)30084-7

journal_volume

61

pub_type

杂志文章,评审
  • Quantifying left ventricular function in heart failure: What makes a clinically valuable parameter?

    abstract::In heart failure (HF) management, noninvasive quantification of left ventricular (LV) function is rapidly evolving. Deformation parameters, such as strain, continue to challenge the central role of ejection fraction (EF) in diagnosis and prognostication of LV dysfunction in HF. The increasing recognition and use of de...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.05.007

    authors: Harbo MB,Nordén ES,Narula J,Sjaastad I,Espe EKS

    更新日期:2020-01-01 00:00:00

  • Coronary heart disease: the female heart is vulnerable.

    abstract::During the past decade, an overall theme has emerged, validating the exploration of gender-based differences in coronary heart disease (CHD) as a basis for clinical strategies to improve outcomes for women. Underrepresentation of women in most of CHD and lack of gender-specific reporting in many clinical trials contin...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2003.08.003

    authors: Wenger NK

    更新日期:2003-11-01 00:00:00

  • Multimodality imaging in bicuspid aortic valve.

    abstract::Bicuspid aortic valve (BAV) patients are at increased risk of valve dysfunction and ascending aorta aneurysm. Imaging techniques are essential to establish diagnosis, identify complications and indicate surgical treatment. Transthoracic echocardiography (TTE) is the imaging technique of choice to diagnose BAV, valve m...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.06.003

    authors: Galian-Gay L,Rodríguez-Palomares J,Guala A,Michelena HI,Evangelista A

    更新日期:2020-01-01 00:00:00

  • Systemic and local inflammation in patients with unstable atherosclerotic plaques.

    abstract::The response to injury in the vasculature and the heart is inflammation. Atherosclerosis is often the result of injury followed by inflammation and atherosclerosis. Vascular and myocardial infections from various pathogens, including viruses, bacteria, chlamydia, and other infections result in vascular inflammation an...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2002.123782

    authors: Willerson JT

    更新日期:2002-05-01 00:00:00

  • Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia.

    abstract::Tachycardia is a strong predictor of both hypertension and excessive cardiovascular risk. This association is robust and prevails after multivariate adjustments for other cardiovascular risk factors. Despite the strong evidence, various guidelines do not list tachycardia as a risk factor because of unwarranted assumpt...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2009.06.002

    authors: Julius S

    更新日期:2009-07-01 00:00:00

  • Chronic thromboembolic pulmonary hypertension: a review of current practice.

    abstract::Pulmonary artery hypertension is a complex and multi-faceted disease process with numerous etiologies. Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed and highly treatable form of pulmonary hypertension. In this disease, certain patients with a history of pulmonary thromboembolic disease go ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.07.005

    authors: Haythe J

    更新日期:2012-09-01 00:00:00

  • Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.

    abstract::Because not all laboratories use the monitoring and stimulation protocols used in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial, we reanalyzed the ESVEM patients' data using alternative, commonly used Holter monitor (HM) and programmed stimulation efficacy criteria to determine if d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0033-0620(96)80029-6

    authors: Reiffel JA,Reiter MJ,Freedman RA,Mann D,Huang SK,Hahn E,Hartz V,Mason J,ESVEM Investigators.

    更新日期:1996-03-01 00:00:00

  • Exercise Reveals Proline Dehydrogenase as a Potential Target in Heart Failure.

    abstract::The benefits of physical activity in cardiovascular diseases have long been appreciated. However, the molecular mechanisms that trigger and sustain the cardiac benefits of exercise are poorly understood, and it is anticipated that unveiling these mechanisms will identify novel therapeutic targets. In search of these m...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.03.002

    authors: Moreira JBN,Wohlwend M,Fenk S,Åmellem I,Flatberg A,Kraljevic J,Marinovic J,Ljubkovic M,Bjørkøy G,Wisløff U

    更新日期:2019-01-01 00:00:00

  • The role of cardiovascular magnetic resonance in patients with acute coronary syndromes.

    abstract::Cardiovascular magnetic resonance (CMR) imaging is a recognized technique for characterization of myocardial tissue in stable ischemic heart disease. In addition, CMR is emerging as a noninvasive imaging tool that can provide supporting information to guide treatment in acute coronary syndromes (ACSs). The advantages ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.001

    authors: Dall Armellina E,Choudhury RP

    更新日期:2011-11-01 00:00:00

  • Epidemiology of Physical Activity and Exercise Training in the United States.

    abstract::The purpose of this review was to provide an overview of the descriptive epidemiology of physical activity (PA) and exercise training in the United States. Overall, there is a low prevalence of meeting the current PA guidelines in all age, sex and race/ethnic groups. Among adults the prevalence of meeting the aerobic ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.01.004

    authors: Katzmarzyk PT,Lee IM,Martin CK,Blair SN

    更新日期:2017-01-01 00:00:00

  • Exercise blood pressure, cardiorespiratory fitness and mortality risk.

    abstract:OBJECTIVE:To assess the cardiorespiratory fitness (CRF) impact on the association between exercise blood pressure (BP) and mortality risk. PATIENTS AND METHODS:We assessed CRF in 15,004 US Veterans (mean age 57.5 ± 11.2 years) who completed a standardized treadmill test between January 1, 1988 and July 28, 2017 and ha...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2021.01.003

    authors: Kokkinos P,Faselis C,Sidossis L,Zhang J,Samuel IBH,Ahmed A,Karasik P,Pittaras A,Doumas M,Grassos C,Rosenberg S,Myers J

    更新日期:2021-01-26 00:00:00

  • Precision Medicine, Healthy Living and the Complex Patient: Managing the Patient With Multimorbidity.

    abstract::Multimorbidity is the most common chronic health condition in adults and is associated with poor health outcomes. Optimal care for people with multimorbidity requires a person-centred approach that considers goals and preferences, improves quality of life and coordinates care across services. Because care is focused o...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.12.010

    authors: Holland AE,Lee AL

    更新日期:2019-01-01 00:00:00

  • The cellular ionic basis of hypertension and allied clinical conditions.

    abstract::Two central concepts of human hypertensive disease remain poorly understood: (1) elevated blood pressure as merely one component of an underlying systemic condition, characterized by multiple defects in diverse tissues (eg, "Syndrome X"), and (2) the heterogeneity of hypertension, in which different and even opposite ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(99)70006-x

    authors: Resnick L

    更新日期:1999-07-01 00:00:00

  • Advanced Imaging Techniques for Mitral Regurgitation.

    abstract::Mitral regurgitation (MR) is one of the most commonly encountered valvular lesions in clinical practice. MR can be either primary (degenerative) or secondary (functional) depending on the etiology of MR and the pathology of the mitral valve (MV). Echocardiography is the primary diagnostic tool for MR and is key in det...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.10.001

    authors: Quien MM,Vainrib AF,Freedberg RS,Bamira DG,Benenstein RJ,Williams MR,Saric M

    更新日期:2018-01-01 00:00:00

  • Nonvascular stents.

    abstract::Stents or endoprostheses have evolved since their introduction. Initially used only in the vascular system, the use of stents has expanded to use in the biliary, urinary, and gastrointestinal tracts and in the tracheo-bronchial tree. Current use of stents includes treatment of both benign and malignant conditions, wit...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(96)80025-9

    authors: Vanderburgh L,Ho CS

    更新日期:1996-09-01 00:00:00

  • Infective endocarditis of the mitral valve: optimal management.

    abstract::Infective endocarditis continues to be associated with significant morbidity and mortality despite recent advances in its management and remains a serious and challenging condition requiring a multidisciplinary approach. Surgery is essential in at least 50% of cases. Surgical outcomes have improved with the introducti...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2008.08.007

    authors: Zakkar M,Chan KM,Amirak E,Herrey A,Punjabi PP

    更新日期:2009-05-01 00:00:00

  • Exploring predisposition and treatment response--the promise of genomics.

    abstract::Spurred by large-scale public and private efforts as well as technological developments, the last few years have seen a major leap forward in our understanding of the genetic basis of cardiovascular disease. This revolution is in its infancy and will continue to alter the medical landscape for years to come. There is ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.04.006

    authors: Pan S,Knowles JW

    更新日期:2012-07-01 00:00:00

  • Peripheral circulation in arterial hypertension.

    abstract::The underlying causes of hypertensive disease remain unclear. This article has attempted to highlight potential dysfunctions in arterial pressure regulation which could either initiate or sustain the hypertensive process. As has been suggested innumerable times hypertension must certainly be a multifactorial abnormali...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(76)90001-3

    authors: Brody MJ,Zimmerman BG

    更新日期:1976-03-01 00:00:00

  • Baroreflex function in hypertension: consequences for antihypertensive therapy.

    abstract::Studies performed in experimental animal models of hypertension as well as in human hypertension have unequivocally shown that reflex cardiovascular control undergoes profound changes with high blood pressure and participates throughout direct and indirect mechanisms at the development and progression of hypertension-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.03.002

    authors: Grassi G,Trevano FQ,Seravalle G,Scopelliti F,Mancia G

    更新日期:2006-05-01 00:00:00

  • Global health assistance for chronic illness: a look at the practical.

    abstract::The changing pattern of disease in the developing world calls for a change in the structure, goals, and personnel of global health assistance. Chronic diseases are now the dominant threat to health and are becoming a challenge to economic advancement in developing economies. Because confronting these diseases, heart d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2007.11.006

    authors: Greenberg H,Raymond SU,Leeder SR

    更新日期:2008-07-01 00:00:00

  • Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston Collaborative Drug Surveillance Program.

    abstract::This study systematically analyzed the incidence and variety of adverse reactions to quinidine sulfate in 652 consecutively monitored hospitalized patients. Fourteen percent of the patients sustained adverse reactions of sufficient severity to warrant discontinuation of the drug. These reactions include GI intolerance...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(77)90004-4

    authors: Cohen IS,Jick H,Cohen SI

    更新日期:1977-09-01 00:00:00

  • Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.

    abstract::The role of antiarrhythmic agents in the post-MI patients has been investigated for several years. Recently, clinical trials have assessed the effects of amiodarone in the post-MI population. The Basel Antiarrhythmic Study of Infarct Survival (BASIS) trial showed a reduction in total mortality, sudden death, and life-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80023-6

    authors: Jafri SM,Borzak S,Goldberger J,Gheorghiade M

    更新日期:1998-07-01 00:00:00

  • QT Variability Index.

    abstract::The QT Variability Index (QTVI) is a non-invasive measure of repolarization lability that has been applied to a wide variety of subjects with cardiovascular disease. It is a ratio of normalized QT variability to normalized heart rate variability, and therefore includes an assessment of autonomic nervous system tone. T...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.07.004

    authors: Dobson CP,Kim A,Haigney M

    更新日期:2013-09-01 00:00:00

  • Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?

    abstract::There are >1.4 million adult congenital heart disease (CHD; ACHD) patients living in the United States. Coronary artery disease (CAD) is at least as prevalent in ACHD patients as in the general population and has become a leading cause of their mortality. In the majority of cases, CAD in the ACHD population is driven ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.018

    authors: Awerbach JD,Krasuski RA,Camitta MGW

    更新日期:2018-01-01 00:00:00

  • Clinical and research measurement techniques of the pulmonary circulation: the present and the future.

    abstract::There has been a lot of progress in measurement techniques of the pulmonary circulation in recent years, and this has required updating of basic physiological knowledge. Pulmonary artery pressures (PAP) are normally low and dependent on left atrial pressure (LAP) and cardiac output (CO). Therefore, defining the functi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2014.12.003

    authors: Naeije R,D'Alto M,Forfia PR

    更新日期:2015-03-01 00:00:00

  • Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.

    abstract::Several randomized trials and meta-analyses have shown that primary angioplasty is superior to thrombolysis in the treatment of ST-segment elevation myocardial infarction (MI) in terms of death, reinfarction, and stroke. However, primary angioplasty should be regarded as the preferred strategy as long as it can not be...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2007.11.004

    authors: De Luca G,Suryapranata H,Marino P

    更新日期:2008-03-01 00:00:00

  • Evaluation of suspected right ventricular pathology in the athlete.

    abstract::Rigorous training remodels the heart of elite endurance athletes to produce the phenotype of the "athlete's heart." This remodeling, which advantages cardiac performance, creates challenges in the diagnosis of cardiac disorders within this population. This is particularly so for right ventricular pathologies because o...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.01.005

    authors: Sniderman JD,Sado DM,Sniderman AD,McKenna WJ

    更新日期:2012-03-01 00:00:00

  • Pathophysiological basis of syncope and neurological conditions that mimic syncope.

    abstract::The definition of syncope has clinical and pathophysiological parts. The clinical part is that syncope is a form of transient loss of consciousness (TLOC), while the pathophysiological element is that syncope differs from other forms of TLOC by virtue of the basis of true syncope - specifically cerebral hypoperfusion....

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.10.016

    authors: van Dijk JG,Wieling W

    更新日期:2013-01-01 00:00:00

  • Transcatheter repair of tricuspid regurgitation with MitraClip.

    abstract::Transcatheter therapy with the MitraClip system (Abbott Structural, Menlo Park, CA) is the most commonly used transcatheter therapy for patients with tricuspid regurgitation, with over 1000 cases performed worldwide. The procedure is an off-label approach that requires meticulous attention to anatomical features obtai...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.10.001

    authors: Sorajja P,Cavalcante JL,Gossl M,Bae R

    更新日期:2019-01-01 00:00:00

  • How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

    abstract::There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.12.008

    authors: Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

    更新日期:2020-12-28 00:00:00